Last week, the pharma giant Pfizer claimed that its in-development COVID-19 vaccine has been 90%+ effective in early tests.
Tired of hearing everyone say, “If I had to grab a beer with a pharma firm, it would be Pfizer,” Moderna Therapeutics just placed the efficacy of its own vaccine test at 94.5%.
To be sure, both companies still face a number of big challenges, ranging from replicating the results in the real world to the logistics of delivering the vaccines.
This is all still extremely tentative, of course. But there are organizations already bracing for some semblance of a return to normality.
Pitchbook highlights a number of companies that are expanding their startup offerings into enterprise contact tracing.
“Previously, contact tracing was a manual, time-consuming process that relied on spreadsheets, pen and paper, and telephones,” writes the private market data platform. “COVID-19 exposed the need to digitize tracing.”
While many countries are working on nation-scale contract tracing, there may be opportunities for more narrow use cases.
Among the players:
TBH, this all sounds a tad… dystopian.
On the bright side, though, this GIF from Hipla’s website suggests the post-COVID workplace may also be the greatest game of Pac-Man ever: